Coenzyme Q10 (ubiquinone), 150 mg, riboflavin (vitamin B2) 400 mg and magnesium 600 mg daily (Migravent® in Germany, Dolovent® in USA) divided into two capsules in the morning and 2 capsules in the evening, taken either with meals or after meals in a placebo-controlled double-blind, randomized clinical trial of 130 migraine patients (18-65 years of age) treated for 3 months led to a significant reduction in migraine attacks per month, migraine severity and headache scores with minimal side effects of occasional loose stools from the magnesium. This combination of nutrients are all cofactors in mitochondrial energy production. “Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial,” J Headache Pain. 2015;16:32. 50981 (1/2016) Priv.-Doz. Dr. med. Charly Gaul, Director of the Migraine and Headache Clinic Königstein, Neurologist, Pain Specialist, Ölmühlweg 31, 61462 Königstein im Taunus, Germany, +49 (0) 6174-29040 / + 49 (0) 6174-2904100 (FAX), firstname.lastname@example.org / www.migraene-klinik.de/
Be and Stay Well,
You may call Kirk Hamilton PA-C Monday thru Friday 8-9 a.m. PST at 916-489-4400 for brief medical questions at Health Associates Medical Group.